Preliminary Evaluation of the Diagnostic Usefulness of Uroplakin 2 with an Assessment of the Antioxidant Potential of Patients with Bladder Cancer

BACKGROUND: Urothelial carcinoma is the most common type of bladder cancer (BC). It makes up more than 90% of all bladder cancers. Uroplakins are tissue-specific, glycoproteins, playing a role in the construction and function of urothelium. The emergence of uroplakins in the urine and/or plasma may...

Descripción completa

Detalles Bibliográficos
Autores principales: Matuszewski, M., Szymańska, B., Długosz, A., Małkiewicz, B., Dembowski, J., Piwowar, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6304619/
https://www.ncbi.nlm.nih.gov/pubmed/30627578
http://dx.doi.org/10.1155/2018/8693297

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6304619/
https://www.ncbi.nlm.nih.gov/pubmed/30627578
http://dx.doi.org/10.1155/2018/8693297

Ejemplares similares